Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/nri2297.

Title:
CCR7 and its ligands: balancing immunity and tolerance | Nature Reviews Immunology
Description:
In this Review, Reinhold Förster and colleagues highlight recent advances in the understanding of how CC-chemokine receptor 7 (CCR7) and its two ligands, CCL19 and CCL21, contribute to both immunity and tolerance. A key feature of the immune system is its ability to induce protective immunity against pathogens while maintaining tolerance towards self and innocuous environmental antigens. Recent evidence suggests that by guiding cells to and within lymphoid organs, CC-chemokine receptor 7 (CCR7) essentially contributes to both immunity and tolerance. This receptor is involved in organizing thymic architecture and function, lymph-node homing of naive and regulatory T cells via high endothelial venules, as well as steady state and inflammation-induced lymph-node-bound migration of dendritic cells via afferent lymphatics. Here, we focus on the cellular and molecular mechanisms that enable CCR7 and its two ligands, CCL19 and CCL21, to balance immunity and tolerance.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Education
  • Science
  • Telecommunications

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 41,360,422 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$521,200 per month
Our calculations suggest that Nature.com earns between $347,470 and $955,541 monthly online from display advertisements.

Keywords {🔍}

pubmed, article, google, scholar, cas, cells, immunol, ccr, cell, nature, central, chemokine, ccl, lymphoid, lymph, dendritic, receptor, mice, migration, exp, med, chemokines, regulatory, homing, nodes, tolerance, expression, organs, ligands, immunity, förster, tcell, immune, access, dcs, endothelial, secondary, function, high, node, lymphocyte, antigen, thymus, lymphocytes, naive, venules, ccrdeficient, impaired, development, tissue,

Topics {✒️}

nature portfolio permissions reprints german research foundation privacy policy single-cell rna-sequencing data biomedical research inflammation-induced lymph-node-bound migration post-natal t-cell lymphopoiesis advertising social media author information authors portal surface-bound chemokines capture diabetes expresses l-selectin generalized multi-organ autoimmunity interleukin-2 receptor α-chain author correspondence altered t-cell responses nature rev multiple strain-specific haplotypes t-cell receptor genes secondary lymphoid-organ chemokine nature immunol t-cell autoimmune diseases secondary lymphoid-tissue chemokine regulate immune-cell trafficking chronic antigen-induced arthritis ligands cc-chemokine ligand springerlink instant access t-cell chemokine ccl21 t-cell development steady-state conditions nature nature 416 nature 401 nature 392 permissions memory t-cell subpopulation davalos-misslitz establishing central tolerance ccr7-dependent lymphoid neogenesis cc-chemokine receptor 7 severe combined immunodeficiency predict clinical immunogenicity personal data high endothelial venules steady-state situations efficient b-cell steady-state migration antigen 1-mediated arrest

Schema {🗺️}

WebPage:
      mainEntity:
         headline:CCR7 and its ligands: balancing immunity and tolerance
         description: In this Review, Reinhold Förster and colleagues highlight recent advances in the understanding of how CC-chemokine receptor 7 (CCR7) and its two ligands, CCL19 and CCL21, contribute to both immunity and tolerance. A key feature of the immune system is its ability to induce protective immunity against pathogens while maintaining tolerance towards self and innocuous environmental antigens. Recent evidence suggests that by guiding cells to and within lymphoid organs, CC-chemokine receptor 7 (CCR7) essentially contributes to both immunity and tolerance. This receptor is involved in organizing thymic architecture and function, lymph-node homing of naive and regulatory T cells via high endothelial venules, as well as steady state and inflammation-induced lymph-node-bound migration of dendritic cells via afferent lymphatics. Here, we focus on the cellular and molecular mechanisms that enable CCR7 and its two ligands, CCL19 and CCL21, to balance immunity and tolerance.
         datePublished:
         dateModified:
         pageStart:362
         pageEnd:371
         sameAs:https://doi.org/10.1038/nri2297
         keywords:
            Biomedicine
            general
            Immunology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnri2297/MediaObjects/41577_2008_Article_BFnri2297_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnri2297/MediaObjects/41577_2008_Article_BFnri2297_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnri2297/MediaObjects/41577_2008_Article_BFnri2297_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnri2297/MediaObjects/41577_2008_Article_BFnri2297_Figa_HTML.jpg
         isPartOf:
            name:Nature Reviews Immunology
            issn:
               1474-1741
               1474-1733
            volumeNumber:8
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Reinhold Förster
               affiliation:
                     name:Institute of Immunology, Hannover Medical School
                     address:
                        name:Institute of Immunology, Hannover Medical School,
                        type:PostalAddress
                     type:Organization
                     name:
                     address:
                        name:Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Ana Clara Davalos-Misslitz
               affiliation:
                     name:Institute of Immunology, Hannover Medical School
                     address:
                        name:Institute of Immunology, Hannover Medical School,
                        type:PostalAddress
                     type:Organization
                     name:
                     address:
                        name:Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Antal Rot
               affiliation:
                     name:Novartis Institutes for BioMedical Research
                     address:
                        name:Novartis Institutes for BioMedical Research, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:CCR7 and its ligands: balancing immunity and tolerance
      description: In this Review, Reinhold Förster and colleagues highlight recent advances in the understanding of how CC-chemokine receptor 7 (CCR7) and its two ligands, CCL19 and CCL21, contribute to both immunity and tolerance. A key feature of the immune system is its ability to induce protective immunity against pathogens while maintaining tolerance towards self and innocuous environmental antigens. Recent evidence suggests that by guiding cells to and within lymphoid organs, CC-chemokine receptor 7 (CCR7) essentially contributes to both immunity and tolerance. This receptor is involved in organizing thymic architecture and function, lymph-node homing of naive and regulatory T cells via high endothelial venules, as well as steady state and inflammation-induced lymph-node-bound migration of dendritic cells via afferent lymphatics. Here, we focus on the cellular and molecular mechanisms that enable CCR7 and its two ligands, CCL19 and CCL21, to balance immunity and tolerance.
      datePublished:
      dateModified:
      pageStart:362
      pageEnd:371
      sameAs:https://doi.org/10.1038/nri2297
      keywords:
         Biomedicine
         general
         Immunology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnri2297/MediaObjects/41577_2008_Article_BFnri2297_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnri2297/MediaObjects/41577_2008_Article_BFnri2297_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnri2297/MediaObjects/41577_2008_Article_BFnri2297_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnri2297/MediaObjects/41577_2008_Article_BFnri2297_Figa_HTML.jpg
      isPartOf:
         name:Nature Reviews Immunology
         issn:
            1474-1741
            1474-1733
         volumeNumber:8
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Reinhold Förster
            affiliation:
                  name:Institute of Immunology, Hannover Medical School
                  address:
                     name:Institute of Immunology, Hannover Medical School,
                     type:PostalAddress
                  type:Organization
                  name:
                  address:
                     name:Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Ana Clara Davalos-Misslitz
            affiliation:
                  name:Institute of Immunology, Hannover Medical School
                  address:
                     name:Institute of Immunology, Hannover Medical School,
                     type:PostalAddress
                  type:Organization
                  name:
                  address:
                     name:Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Antal Rot
            affiliation:
                  name:Novartis Institutes for BioMedical Research
                  address:
                     name:Novartis Institutes for BioMedical Research, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature Reviews Immunology
      issn:
         1474-1741
         1474-1733
      volumeNumber:8
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Institute of Immunology, Hannover Medical School
      address:
         name:Institute of Immunology, Hannover Medical School,
         type:PostalAddress
      name:
      address:
         name:Germany
         type:PostalAddress
      name:Institute of Immunology, Hannover Medical School
      address:
         name:Institute of Immunology, Hannover Medical School,
         type:PostalAddress
      name:
      address:
         name:Germany
         type:PostalAddress
      name:Novartis Institutes for BioMedical Research
      address:
         name:Novartis Institutes for BioMedical Research, Vienna, Austria
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Reinhold Förster
      affiliation:
            name:Institute of Immunology, Hannover Medical School
            address:
               name:Institute of Immunology, Hannover Medical School,
               type:PostalAddress
            type:Organization
            name:
            address:
               name:Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Ana Clara Davalos-Misslitz
      affiliation:
            name:Institute of Immunology, Hannover Medical School
            address:
               name:Institute of Immunology, Hannover Medical School,
               type:PostalAddress
            type:Organization
            name:
            address:
               name:Germany
               type:PostalAddress
            type:Organization
      name:Antal Rot
      affiliation:
            name:Novartis Institutes for BioMedical Research
            address:
               name:Novartis Institutes for BioMedical Research, Vienna, Austria
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Institute of Immunology, Hannover Medical School,
      name:Germany
      name:Institute of Immunology, Hannover Medical School,
      name:Germany
      name:Novartis Institutes for BioMedical Research, Vienna, Austria
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(299)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

4.67s.